05-06 Oct 2022
Wed-Thurs
Hilton Munich Airport, Germany

17th Drug Discovery Innovation
Programme

About The Event

Join us in October 2022 to experience 2-days of top-level strategic content and the current scientific insights, networking, and discussions from leading global pharmaceutical R&D executives.

With over 100+ attendees, learn how new technologies and innovative processes are fundamentally changing what the drug discovery research will look like in the next two to five years.

This year’s Drug Discovery Innovation Programme will highlight the challenges discovery pipelines have faced due to COVID-19 and will put a spotlight on the adoption of technology to combat these.

Our Services

Thought Leadership Opportunities

Take the stage in front of a captive and focused audience to exhibit your skills and market knowledge.

Marketing & Branding Opportunities

Be the name that all decision makers remember when looking for answers, and be the brand that comes to mind.

Exhibiting
Opportunities

We offer a one-of-a-kind platform for businesses to boost brand success via engagement and meaningful relationships.

Prequalified 1-2-1 Business Meetings

Take your pick from our tailored packages to make the most of your time on site and develop long-term, value-adding business partnerships.

Our 2022 Thought Leaders

Conference Chair

Worldbi Drug Discovery Speaker

Patrizia D'Alessio

CEO

Industry Speakers

Worldbi Drug Discovery Speaker

Imran Khan

Senior Scientist

Worldbi Drug Discovery Speaker

Ulrich Betz

Vice President of Innovation

Worldbi Drug Discovery Speaker

Philippe Lienard

Pre-Clinical Leader

Worldbi Drug Discovery Speaker

Abhishek Pandey

Group Lead-Raiders: Pharma Discovery

Worldbi Drug Discovery Speaker

Nils Jakob Vest Hansen, PhD

CEO and Founder

Worldbi Drug Discovery Speaker

Nicolas Bery

Senior Postdoctoral Scientist

Worldbi Drug Discovery Speaker

Pelin Candarlioglu

Cell Biologist/Bioengineer - Complex in Vitro Models

Worldbi Drug Discovery Speaker

Hans-Åke Fabricius

CVO, Scientific Consultant

Worldbi Drug Discovery Speaker

Stefano Sainas

Postdoctoral Researcher

Worldbi Drug Discovery Speaker

Christine Rothe

Vice President, Early-Stage Project Leadership & Data Science

Worldbi Drug Discovery Speaker

S. Stephen Yi

Director of Bioinformatics, Faculty of Oncology and Biomedical Engineering

Worldbi Drug Discovery Speaker

Shay Weiss

Head of Novartis DevOps

Worldbi Drug Discovery Speaker

Jonathan Mason

Senior Research Fellow, Computational Chemistry

Sponsor Speakers

Worldbi Drug Discovery Speaker

Richard Middleton

Director, Business Development - Europe

Worldbi Drug Discovery Speaker

Dr John Unitt

Vice President, Immunology and Inflammation

Worldbi Drug Discovery Speaker

Ray Boffey

Executive Director of Medicines Research

Worldbi Drug Discovery Speaker

Dr. Teodor Aastrup

CEO

Worldbi Drug Discovery Speaker

Jasper Levink

Chief Business Officer

25

DISCUSSION TOPICS

25 SPEAKERS
100 ATTENDEES
12 Networking Hours

TESTIMONIALS

what people say

“One-on one meetings are very good, very informal, relax and gives you very nice partnering opportunities.”

CO-FOUNDER 3Z ehf
“I've met individuals, potential customers, and collaborators. The event saves you time and effort, particularly in terms of networking and business growth.”
SR. DIRECTOR OF BUSINESS DEVELOPMENT. Nuchem Therapeutics

“I liked the networking where you could meet lot of people and have one-on-one meeting.”

VP PHARMACOLOGY TocopheR

Who Will Attend

Delegates Will Include VPs, Global Heads, Directors and Managers


Bioinformatics
Innovation
Research
R&D Senior Scientist
Computational Chemist
Principal Research Scientist
Translational Oncology
Data Scientist
Non-Clinical Development
Biology
Early Research
Non-Clinical Biostatistics
Translational Immunology
Pharmaceutical Research
Discovery R&D
Senior Scientist
Medical Chemistry
Analytical Sciences
Machine Learning Research
Intelligent Systems Laboratory

Event Venue

Explore Munich and its rich Culture, Architecture, and Cuisine!

Hilton Munich Airport, Germany

Lifestyle is a priority in Munich. It might be down to the clear blue skies or simply the city's beauty. A city with a big heart. Munich is a fun-loving city, known for its seasonal festivals and rich cultural calendar, so along with visiting the beautiful churches and outstanding museums and palaces, you should spend some time enjoying life.

Event Schedule

Have a look at Schedule

Registration & Itinerary Collection with Welcome Coffee

Welcome from World BI

Brenden Legros

Chairperson Welcome Address

Patrizia D’Alessio - CEO, AISA Therapeutics

Hubert Hirthe

Presentation 1: R&D Unraveling New Endpoints of Drug Discovery

Patrizia D’Alessio - CEO, AISA Therapeutics

Cole Emmerich

Presentation 2: Attana Outperforms Competition in All Relevant Verticals for Biological Relevance Selection, Optimization and Validation Improving Efficacy & Decreasing Toxicity

Teodor Aastrup - CEO, Attana AB

Jack Christiansen

Presentation 3: GPCR Structure-Based Drug Design: Lessons Learnt and Future Directions

Jonathan Mason - Senior Research Fellow, Computational Chemistry, Orexia Therapeutics

Networking Coffee Break

Jack Christiansen

Presentation 4: MEDS433 a Novel and Potent human Dihydroorotate Dehydrogenase (hDHODH) Inhibitor, Induces Differentiation and apoptosis of Acute Myeloid Leukemia

Stefano Sainas - Assistant Professor, University of Turin

Jack Christiansen

Presentation 5: Big Drugs, Little Drugs - Capitalizing on Large Molecule Progress

Dr. John Unitt - VP Immunology & Inflammation

Sygnature Discovery

Jack Christiansen

Presentation 6: The Future Technology Road Map for HCP and Consumer engagement – Talking about AI, ML, Big Data, for Creating Next Generation of Technology Eco System

Shay Weiss - Director of Omnichannel Engineering, Novartis

Jack Christiansen

Presentation 7: TBC

Richard Middleton - Director Business Development - EU, Jubilant Biosys Ltd

Lunch Break

Jack Christiansen

Presentation 8: Domainex: Integrated Drug Discovery

Dr Ray Boffey - Executive Director of Medicines Research, Domainex

Jack Christiansen

Presentation 9: DEL Screening Inside Living Cells

Nils Jakob Vest Hansen, PhD - CEO, Vipergen ApS

Jack Christiansen

Presentation 10: How ALiCE - the First Scalable Eukaryotic Cell-free Lysate - Can Change the Way Drugs are Discovered & Developed?

Jasper Levink - Chief Business Officer, LenioBio

Networking Coffee Break

Jack Christiansen

Presentation 11: 350 Years of Curiosity and Innovation

Dr. Ulrich A.K. Betz - VP Innovation | Head - Department Innovation Incubator

Merck Group

Jack Christiansen

Presentation 12: Designing New Drug Therapies Using Natural and Synthetic Ingredients: Advances and Oppurtunities

Hans-Åke Fabricius - CVO | Scientific Consultant, Cell receptor GmbH

Q/A Session

Chair's Closing Remarks

Drinks Reception

End Of Day1

Registration & Itinerary Collection with Welcome Coffee

Welcome from World BI

Brenden Legros

Chairperson Welcome Address

Patrizia D’Alessio - CEO, AISA Therapeutics

Brenden Legros

Presentation 14: TBC

Christine Rothe - Vice President | Early-stage Project Leadership & Data Science, Pieris Pharmaceuticals

Hubert Hirthe

Presentation 15: Early Developbility Assessment, Key to Success for Development Phases

Phillippe Lienard - Pre-clinical Leader, Pasteur Institue

Cole Emmerich

Presentation 16: Intracellular Antibodies as Next Generation Anti-cancer Therapy

Dr. Nicolas Bery, PhD - Sr. Postdoctoral Scientist, Cancer Research Centre of Toulouse (CRCT)

Networking Coffee Break

Jack Christiansen

Presentation 17: Investigational & Computational Approaches: Mole Fraction Solubility of GLN in Organic Solvents API to Estimate Impurities

Pelin Candarlioglu - Cell Biologist/Bioengineer | Complex in Vitro Models, GSK

Jack Christiansen

Presentation 18: Machine Learning in Drug Discovery: Use Cases or ML in Multiomics: Use Cases

Abhishek Pandey - Principal Research Scientist, Abbvie

Jack Christiansen

Presentation 19: Cancer Networks and AI-based Drug Discovery

Song (Stephen) Yi - Faculty of Dell Medical School and Biomedical Engineering | Director of Bioinformatics, The University of Texas at Austin

Presentation 20: Designing New Drug Therapies Using Natural or Synthetic Ingredients: Advances and Opportunities

Chair's Closing Remarks

Lunch Break

End Of Conference

Book your seat online

Get yours why they are still available

Hot!
Global Marketing
£799



  • Inclusion of company logo and profile in welcome pack
  • Global marketing and branding for lead generation purpose



Buy Now

Hot!
Physical Pass
£1,999
  • 01 Attendee Pass
  • Access to the Conference for Two Days
  • Networking Lunch and Coffee Seats
  • Networking Drink Reception Seat
  • Hard Copy of Attendee Welcome Pack
  • Inclusion of company and personal profile in welcome pack
  • Global marketing and branding for lead generation purpose
Buy Now

Our Partners

We have Partners not Sponsors

Media Partners

Partners with us

Related Events